![IL-5 production by OVA-stimulated lymphocytes isolated from the lung... | Download Scientific Diagram IL-5 production by OVA-stimulated lymphocytes isolated from the lung... | Download Scientific Diagram](https://www.researchgate.net/profile/Mirjam-Kool/publication/13492866/figure/fig5/AS:601793818001415@1520490235696/IL-5-production-by-OVA-stimulated-lymphocytes-isolated-from-the-lung-airway-tissue-from_Q640.jpg)
IL-5 production by OVA-stimulated lymphocytes isolated from the lung... | Download Scientific Diagram
![Screening for 3D Environments That Support Human Mesenchymal Stem Cell Viability Using Hydrogel Arrays | Tissue Engineering Part A Screening for 3D Environments That Support Human Mesenchymal Stem Cell Viability Using Hydrogel Arrays | Tissue Engineering Part A](https://www.liebertpub.com/cms/10.1089/ten.tea.2008.0096/asset/images/medium/fig-1.gif)
Screening for 3D Environments That Support Human Mesenchymal Stem Cell Viability Using Hydrogel Arrays | Tissue Engineering Part A
![Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths](https://www.science.org/cms/10.1126/sciimmunol.abl4340/asset/b3df957b-9692-485b-be8f-75be8cfec156/assets/images/large/sciimmunol.abl4340-f3.jpg)
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
![Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results - Cytotherapy Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results - Cytotherapy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f6bc297a-d094-44b8-9df6-f6aab6a87ed9/jcyt925-fig-0001.jpg)
Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results - Cytotherapy
![Screening for 3D Environments That Support Human Mesenchymal Stem Cell Viability Using Hydrogel Arrays | Tissue Engineering Part A Screening for 3D Environments That Support Human Mesenchymal Stem Cell Viability Using Hydrogel Arrays | Tissue Engineering Part A](https://www.liebertpub.com/cms/10.1089/ten.tea.2008.0096/asset/images/medium/fig-8.gif)
Screening for 3D Environments That Support Human Mesenchymal Stem Cell Viability Using Hydrogel Arrays | Tissue Engineering Part A
![Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths](https://www.science.org/cms/10.1126/sciimmunol.abl4340/asset/9b4d593f-60af-4a17-aafa-5ab9cbfae006/assets/images/large/sciimmunol.abl4340-f1.jpg)
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
![Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths](https://www.science.org/cms/10.1126/sciimmunol.abl4340/asset/086b96de-b645-44cf-ac5f-ca5886c76707/assets/images/large/sciimmunol.abl4340-f2.jpg)